 Beginning 3-21 days after surgery, patients undergo brachytherapy via the GliaSite RTSTM applicator. Within 30 days of brachytherapy no more than 60 days after resection patients undergo external beam radiotherapy 5 days a week for 6 weeks in the absence of disease progression or unacceptable toxicity. 